H.R. 941 — 117th Congress
TRANSPLANT Act of 2021
Sponsor
Latest action
May 26, 2021Became Public Law No: 117-15.
CRS summary
As of May 26, 2021Public Law
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021
This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant.
The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.
In addition, the Government Accountability Office must report on the regenerative medicine workforce.
Congressional Research Service, via api.congress.gov (public domain)
Roll-call votes
1 on recordApr 15, 2021 · On Motion to Suspend the Rules and Pass
Full roll callYea — 415: 215 D · 200 R
Nay — 2: 2 R
| Member | State |
|---|---|
| Lauren Boebert | CO |
| Marjorie Taylor Greene | GA |
Not Voting — 12: 10 R · 2 D
Member pages currently show roll-call votes from the 119th Congress only. The “Member pages” column marks votes from that congress.